克隆形成试验
体内
体外
细胞
细胞毒性T细胞
阿霉素
药理学
药代动力学
化学
药品
球体
癌症研究
免疫学
生物
医学
内科学
化疗
生物化学
生物技术
出处
期刊:PubMed
日期:1991-07-01
卷期号:5 (4): 385-8
被引量:2
摘要
Doxorubicin has been shown to be more effective against MGH-U1 bladder carcinoma cells grown in monolayer than spheroid. In vitro clonogenic cell survival curves have been replotted against the area under the concentration-time curve (AUC) for drug exposure and fitted to a Hill plot to derive the parameters E max (maximum possible cell kill) and C50 (drug exposure resulting in half the maximum cell kill). The plasma AUC following intraperitoneal administration of doxorubicin to nude mice was measured using a sensitive and specific HPLC assay and combined with the in vitro cell survival parameters to predict the clonogenic cell survival in MGH-U1 xenografts. The Hill parameters from the spheroid model are better predictors of xenograft clonogenic cell survival than the monolayer parameters. It is possible to predict clonogenic cell survival in solid tumours on the basis of the pharmacokinetics of cytotoxic drug exposure, using a mathematical model based on clonogenic cell kill in vitro.
科研通智能强力驱动
Strongly Powered by AbleSci AI